Canada
PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Psychedelics
TripSitter says the acquisition will be 'instrumental' for the future of the company
Canada
The non-profit trade association received a high level of interest from multiple branches of government
Canada
From psilocybin mushroom cultivators to artists and Indigenous leaders, the conference united a broad range of people
Canada
Trial will evaluate the efficacy of synthetic psilocybin drug 'APEX-52' for treating vets with PTSD
International
The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy
Psychedelics
New phase I study will be held at MAC Clinical Research in Manchester, England next year
Canada
11th annual conference will feature prominent speakers and artists including Dennis McKenna, Vanessa Le-Fan Yuen and Paul Stamets joining virtually from Florida
Psychedelics
Algernon will provide cGMP DMT for the study in exchange for part-ownership of IP generated
Psychedelics
The company has enhanced its IP portfolio with a patent that will be valid until 2041
